Failure to Suppress Progression in Clear Cell Renal Cell Carcinoma Associated with NCOA7 Low Expression Revealed Through Radiogenomic Analysis

<b>Background/Objectives</b>: Radiogenomics investigates the relationship between imaging features and genomic characteristics, offering a non-invasive approach to studying tumor biology. Nuclear receptor coactivator 7 (<i>NCOA7</i>) is a conserved nuclear receptor coactivator with potential prognostic relevance in clear cell renal cell carcinoma (ccRCC). This study aims to evaluate the radiogenomic features associated with <i>NCOA7</i> low expression in ccRCC patients and its correlation with tumor aggressiveness. <b>Methods</b>: A cohort of 209 ccRCC patients was analyzed using genomic data from The Cancer Genome Atlas and imaging features from The Cancer Imaging Archive. Imaging characteristics were assessed through computed tomography scans, focusing on tumor size, margins, necrosis, growth patterns, and other radiological features. Statistical analyses, including Student's <i>t</i>-test and Pearson's Chi-square test, were used to examine associations between <i>NCOA7</i> expression and clinicopathological or radiological features, with significance set at <i>p</i> < 0.05. <b>Results</b>: <i>NCOA7</i> low expression was identified in 66.03% of patients and significantly associated with older age (<i>p</i> = 0.001), higher tumor grade (<i>p</i> = 0.015), advanced American Joint Committee of Cancer stage (<i>p</i> = 0.006), collateral vascular supply (<i>p</i> = 0.014), ill-defined margins (<i>p</i> = 0.016), tumor necrosis (<i>p</i> = 0.002), exophytic growth pattern ≥50% (<i>p</i> = 0.002), and perinephric fat stranding (<i>p</i> = 0.027). <b>Conclusions</b>: These findings indicate a radiologic phenotype suggestive of increased tumor aggressiveness. <i>NCOA7</i> low expression correlates with aggressive radiologic and clinicopathological features, underscoring its potential as a biomarker for poor prognosis in ccRCC. Radiogenomic integration provides insights into tumor behavior and aids in developing therapeutic strategies.

Authors

Institutions

Publication Details

Journal
Genes
Published
2025-03-28
DOI
https://doi.org/10.3390/genes16040386
Citations
1
Primary Topic
Renal cell carcinoma treatment
Type
article
Field-Weighted Citation Impact
1.52
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Failure to Suppress Progression in Clear Cell Renal Cell Carcinoma Associated with NCOA7 Low Expression Revealed Through Radiogenomic Analysis

Federico Greco, Bruno Beomonte Zobel, Maria Concetta Cataldo, Carlo Augusto Mallio
1 citations
Genes
Renal cell carcinoma treatment
1.52
article

Failure to Suppress Progression in Clear Cell Renal Cell Carcinoma Associated with NCOA7 Low Expression Revealed Through Radiogenomic Analysis

Federico Greco, Bruno Beomonte Zobel, Maria Concetta Cataldo, Carlo Augusto Mallio
article en
1 citations

Abstract

<b>Background/Objectives</b>: Radiogenomics investigates the relationship between imaging features and genomic characteristics, offering a non-invasive approach to studying tumor biology. Nuclear receptor coactivator 7 (<i>NCOA7</i>) is a conserved nuclear receptor coactivator with potential prognostic relevance in clear cell renal cell carcinoma (ccRCC). This study aims to evaluate the radiogenomic features associated with <i>NCOA7</i> low expression in ccRCC patients and its correlation with tumor aggressiveness. <b>Methods</b>: A cohort of 209 ccRCC patients was analyzed using genomic data from The Cancer Genome Atlas and imaging features from The Cancer Imaging Archive. Imaging characteristics were assessed through computed tomography scans, focusing on tumor size, margins, necrosis, growth patterns, and other radiological features. Statistical analyses, including Student's <i>t</i>-test and Pearson's Chi-square test, were used to examine associations between <i>NCOA7</i> expression and clinicopathological or radiological features, with significance set at <i>p</i> < 0.05. <b>Results</b>: <i>NCOA7</i> low expression was identified in 66.03% of patients and significantly associated with older age (<i>p</i> = 0.001), higher tumor grade (<i>p</i> = 0.015), advanced American Joint Committee of Cancer stage (<i>p</i> = 0.006), collateral vascular supply (<i>p</i> = 0.014), ill-defined margins (<i>p</i> = 0.016), tumor necrosis (<i>p</i> = 0.002), exophytic growth pattern ≥50% (<i>p</i> = 0.002), and perinephric fat stranding (<i>p</i> = 0.027). <b>Conclusions</b>: These findings indicate a radiologic phenotype suggestive of increased tumor aggressiveness. <i>NCOA7</i> low expression correlates with aggressive radiologic and clinicopathological features, underscoring its potential as a biomarker for poor prognosis in ccRCC. Radiogenomic integration provides insights into tumor behavior and aids in developing therapeutic strategies.

GenesVol. 16(4)
Università Campus Bio-Medico (IT), ASL Roma (IT), Istituto Nazionale di Fisica Nucleare, Sezione di Lecce (IT), Campus Bio Medico University Hospital (IT)
No poverty
Openalex Percentile: Top 20%
Renal cell carcinoma treatment
1.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.